213 related articles for article (PubMed ID: 14751928)
21. Transcriptional activation is a key function encoded by MLL fusion partners.
Zeisig BB; Schreiner S; García-Cuéllar MP; Slany RK
Leukemia; 2003 Feb; 17(2):359-65. PubMed ID: 12592336
[TBL] [Abstract][Full Text] [Related]
22. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.
Corral J; Lavenir I; Impey H; Warren AJ; Forster A; Larson TA; Bell S; McKenzie AN; King G; Rabbitts TH
Cell; 1996 Jun; 85(6):853-61. PubMed ID: 8681380
[TBL] [Abstract][Full Text] [Related]
23. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
[TBL] [Abstract][Full Text] [Related]
24. Turning on a dimer: new insights into MLL chimeras.
Hsu K; Look AT
Cancer Cell; 2003 Aug; 4(2):81-3. PubMed ID: 12957280
[TBL] [Abstract][Full Text] [Related]
25. Dimerization of MLL fusion proteins immortalizes hematopoietic cells.
Martin ME; Milne TA; Bloyer S; Galoian K; Shen W; Gibbs D; Brock HW; Slany R; Hess JL
Cancer Cell; 2003 Sep; 4(3):197-207. PubMed ID: 14522254
[TBL] [Abstract][Full Text] [Related]
26. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.
Schreiner SA; García-Cuéllar MP; Fey GH; Slany RK
Leukemia; 1999 Oct; 13(10):1525-33. PubMed ID: 10516753
[TBL] [Abstract][Full Text] [Related]
27. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.
Ayton PM; Cleary ML
Genes Dev; 2003 Sep; 17(18):2298-307. PubMed ID: 12952893
[TBL] [Abstract][Full Text] [Related]
28. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
29. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
Zeleznik-Le NJ; Harden AM; Rowley JD
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10610-4. PubMed ID: 7938000
[TBL] [Abstract][Full Text] [Related]
30. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.
Lavau C; Du C; Thirman M; Zeleznik-Le N
EMBO J; 2000 Sep; 19(17):4655-64. PubMed ID: 10970858
[TBL] [Abstract][Full Text] [Related]
31. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathogenesis of MLL-associated leukemias.
Eguchi M; Eguchi-Ishimae M; Greaves M
Int J Hematol; 2005 Jul; 82(1):9-20. PubMed ID: 16105754
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene.
Dobson CL; Warren AJ; Pannell R; Forster A; Rabbitts TH
EMBO J; 2000 Mar; 19(5):843-51. PubMed ID: 10698926
[TBL] [Abstract][Full Text] [Related]
34. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein.
Yam JW; Jin DY; So CW; Chan LC
Blood; 2004 Feb; 103(4):1445-53. PubMed ID: 14551139
[TBL] [Abstract][Full Text] [Related]
36. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
37. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
Ayton PM; Chen EH; Cleary ML
Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia.
Maki K; Mitani K; Yamagata T; Kurokawa M; Kanda Y; Yazaki Y; Hirai H
Blood; 1999 May; 93(10):3216-24. PubMed ID: 10233872
[TBL] [Abstract][Full Text] [Related]
39. The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.
Fuchs U; Rehkamp G; Haas OA; Slany R; Kōnig M; Bojesen S; Bohle RM; Damm-Welk C; Ludwig WD; Harbott J; Borkhardt A
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8756-61. PubMed ID: 11438682
[TBL] [Abstract][Full Text] [Related]
40. MLL: a histone methyltransferase disrupted in leukemia.
Hess JL
Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]